Johnson & Johnson (JNJ) could be considered "the Teflon® healthcare company", as no matter how many snafus and recalls the company endures, it maintains its image of a top-notch company with impeccable integrity. In its most recent Q4 2011 earnings call,

In our rather terse (due to firm involvement) post on Monday concerning Merck & Co. v. Ratliff, ___ S.W.3d ___, 2012 WL 413522 (Ky. App. Feb. 10, 2012) – beating both BNA and 360 by two days, BTW – we mentioned the “interesting” aspects of that case. Hav

Facing regulatory uncertainty or obstructionism, companies are simply abandoning projects that in a more positive regulatory environment might have yielded medically useful, profitable products. The Small Business Administration estimated the cost of com

WHITEHOUSE STATION, Nueva Jersey--(BUSINESS WIRE)--Merck (NYSE: MRK), conocida fuera de Estados Unidos y Canadá como MSD, ha anunciado hoy la creación de una nueva empresa conjunta (JV, del inglés Joint Venture) con Supera Farma Laboratorios S.A. , una em

WHITEHOUSE STATION, N.J. , Feb 13, 2012 (BUSINESS WIRE) -- Merck, known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) has approved ZIOPTAN(TM) (tafluprost ophthalmic solution) 0.0015%, the fi

HAWTHORNE, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that Jane Wasman, J.D. has been named Chief, Strategic Development. In this new role, Ms. Wasman will oversee the development and execution of the Company’s long-r